Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Debt (2018 - 2025)

Rockwell Medical's Non-Current Debt history spans 10 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 4.18% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $8.8 million, up 4.18%, while the annual FY2025 figure was $8.8 million, 4.18% up from the prior year.
  • Non-Current Debt reached $8.8 million in Q4 2025 per RMTI's latest filing, up from $8.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $21.0 million in Q1 2021 to a low of $3.3 million in Q3 2023.
  • Average Non-Current Debt over 5 years is $9.4 million, with a median of $8.6 million recorded in 2025.
  • Peak YoY movement for Non-Current Debt: crashed 62.83% in 2023, then skyrocketed 151.67% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $13.2 million in 2021, then tumbled by 42.7% to $7.6 million in 2022, then increased by 9.77% to $8.3 million in 2023, then rose by 2.16% to $8.5 million in 2024, then rose by 4.18% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Non-Current Debt are $8.8 million (Q4 2025), $8.7 million (Q3 2025), and $8.6 million (Q2 2025).